Change Healthcare
Get twice-weekly insights on the biggest stories shaping cardiology.
You might also like
Pharmaceuticals July 12, 2026
CARDIO-TTRansform and The Future of ATTR-CM Drugs July 12, 2026
The ATTR-CM drug race almost got another contender, but AstraZeneca and Ionis' Wainua unexpected Phase 3 trial failure might have actually simplified the field.
Heart Failure July 9, 2026
POLY-HF and the Possibility of HF Polypills July 9, 2026
Guideline-directed heart failure therapy works, but the biggest hurdle is getting patients to actually take it and fresh results in Nature from the POLY-HF trial suggest a polypill approach could be the answer.
Heart Failure July 2, 2026
Uncertainty Lingers on VNS for HF After Shortened Study July 2, 2026
Freshly published data from LivaNova’s pivotal ANTHEM-HFrEF trial hinted that vagal nerve stimulation might help patients with HFrEF, but the company's early termination decision left some questions unanswered.